1. A recombinase polymerase amplification–based assay for rapid detection of Chlamydia psittaci
- Author
-
Wencheng Lin, Feng Cong, Qingmei Xie, Yung-Fu Chang, Hongxin Li, Xinheng Zhang, and Yanling Pang
- Subjects
Point-of-Care Systems ,detection ,Recombinase Polymerase Amplification ,urologic and male genital diseases ,Rapid detection ,Sensitivity and Specificity ,Recombinases ,03 medical and health sciences ,chemistry.chemical_compound ,Genotype ,medicine ,Animals ,recombinase polymerase amplification ,Gene ,Poultry Diseases ,030304 developmental biology ,lcsh:SF1-1100 ,Chlamydia psittaci ,0303 health sciences ,biology ,Immunology, Health, and Disease ,0402 animal and dairy science ,Outbreak ,04 agricultural and veterinary sciences ,General Medicine ,Psittacosis ,biology.organism_classification ,medicine.disease ,040201 dairy & animal science ,Virology ,Ducks ,chemistry ,Chlamydophila psittaci ,Atypical pneumonia ,Animal Science and Zoology ,lcsh:Animal culture ,Chickens ,Nucleic Acid Amplification Techniques ,DNA - Abstract
Chlamydia psittaci is a zoonotic agent of systemic wasting disease in birds and atypical pneumonia in mammalians including humans, constituting a public health risk. A rapid diagnostic assay would be beneficial in screening C. psittaci in the field. In this study, we developed a probe-based recombinase polymerase amplification (RPA) assay for the rapid detection of C. psittaci. The specific primer pairs and probe targeting the conserved region of the outer membrane protein A gene were designed and applied to the real-time real-time RPA assay. The test can be performed at 39°C for 20 min using a portable device, with sensitivities approaching 100 copies of DNA molecules per reaction, with no cross-reaction with other pathogens. The clinical performance of the RPA assay was evaluated in an outbreak of C. psittaci and has high accuracy levels in field applications. The epidemic C. psittaci strains were classed into 2 genotypes: A and C. Collectively, this study offers a promising approach in screening for C. psittaci both in a laboratory setting and in field settings, and RPA can be used as an effective clinical test to monitor outbreaks in domestic fowl populations.
- Published
- 2021